share_log

4: Statement of changes in beneficial ownership of securities-Officer Philibert Robert

4: Statement of changes in beneficial ownership of securities-Officer Philibert Robert

4:持股變動聲明-高管 Philibert Robert
美股SEC公告 ·  09/10 17:24

Moomoo AI 已提取核心訊息

On September 6, 2024, Robert Philibert, the Chief Medical Officer of Cardio Diagnostics Holdings, Inc. [CDIO], completed the purchase of a total of 34,075 shares of common stock in two separate transactions. The first transaction involved the acquisition of 26,615 shares at a price of $0.287 per share, while the second transaction saw the purchase of 7,460 shares at $0.2848 per share. Following these transactions, Philibert's total indirect beneficial ownership in the company amounts to 1,683,867 shares. Both acquisitions were made on the open market.
On September 6, 2024, Robert Philibert, the Chief Medical Officer of Cardio Diagnostics Holdings, Inc. [CDIO], completed the purchase of a total of 34,075 shares of common stock in two separate transactions. The first transaction involved the acquisition of 26,615 shares at a price of $0.287 per share, while the second transaction saw the purchase of 7,460 shares at $0.2848 per share. Following these transactions, Philibert's total indirect beneficial ownership in the company amounts to 1,683,867 shares. Both acquisitions were made on the open market.
2024年9月6日,Cardio Diagnostics Holdings, Inc. [CDIO]的首席醫療官Robert Philibert完成了兩筆交易,購買了共計34,075股普通股。第一筆交易涉及26,615股,每股價格爲$0.287;第二筆交易涉及7,460股,每股價格爲$0.2848。此後,Philibert在該公司的間接權益所有權總計達到1,683,867股。這兩筆交易都是在開放市場上進行的。
2024年9月6日,Cardio Diagnostics Holdings, Inc. [CDIO]的首席醫療官Robert Philibert完成了兩筆交易,購買了共計34,075股普通股。第一筆交易涉及26,615股,每股價格爲$0.287;第二筆交易涉及7,460股,每股價格爲$0.2848。此後,Philibert在該公司的間接權益所有權總計達到1,683,867股。這兩筆交易都是在開放市場上進行的。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息